GF Fund Management’s Acrivon Therapeutics ACRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$919 Hold
772
﹤0.01% 654
2025
Q1
$1.57K Buy
772
+118
+18% +$240 ﹤0.01% 655
2024
Q4
$3.94K Buy
+654
New +$3.94K ﹤0.01% 619